+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Avineuro Pharmaceuticals - logo
Schizophrenia Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Schizophrenia Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • March 2024
  • 397 Pages
  • Global
From
Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021 - Product Thumbnail Image

Alzheimer's Disease (Central Nervous System) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 2055 Pages
  • Global
From
Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights - Product Thumbnail Image

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

  • Report
  • March 2019
  • 220 Pages
  • Global
From
Schizophrenia - Pipeline Review, H2 2020 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 440 Pages
  • Global
From
Alzheimer's Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 1785 Pages
  • Global
From
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H2 2018 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) - Pipeline Review, H2 2018

  • Drug Pipelines
  • November 2018
  • 70 Pages
  • Global
From
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 83 Pages
  • Global
From
Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha 2C Adrenergic Receptor (Alpha 2 Adrenergic Receptor Subtype C4 or Alpha 2C Adrenoreceptor or ADRA2C) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 51 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 380 Pages
  • Global
From
Generalized Anxiety Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Generalized Anxiety Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 62 Pages
  • Global
From
Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020 - Product Thumbnail Image

Alpha 2C Adrenergic Receptor - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 50 Pages
  • Global
From
5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021 - Product Thumbnail Image

5-Hydroxytryptamine Receptor 6 - Drugs In Development, 2021

  • Report
  • July 2021
  • 63 Pages
  • Global
From
  • 13 Results (Page 1 of 1)
Loading Indicator